Pharmaceutical Technology reports Alcami’s center of excellence for advanced analytical testing in St. Louis, MO achieved a certificate of compliance by the European Medicines Agency (EMA) during April 2019 for the facilities satisfactory GMP inspection.
As Pharmaceutical Technology reports, Alcami now offers a powerfully EMA compliant analytical testing site in the heartland of America. It opened up the center of excellence in the 200-acre innovation hub and technology district known as St. Louis’s Cortex Innovation Community.
- Alcami’s facility offers biopharma the following services:
- Testing services for new drug entities
- Animal health products
- Rare materials
- In-process good
- Medicated consumer health products
Mayor Lyda Krewson and Missouri House of Representatives honored the site.
Alcami represents a world-class contract drug development and manufacturing organization. With executives offices in Wilmington and Durham, NC they claim they were the first company to offer a solution that is tailored to small and mid-sized biopharma companies. They have over 900 employees and operate at ten global locations. The company generally positions itself to be far more flexible and adaptable than to other comparable ventures that serve big pharma.